Form 4: USANA Director Sells 1,750 Shares

USANA Health Sciences Director John Turman Fleming sold 1,750 shares of common stock at $19.79 per share, reducing his direct beneficial ownership to 4,565 shares.

Summary

• John Turman Fleming, a Director of USANA Health Sciences Inc. (USNA), reported a sale of common stock.
• The transaction involved the disposition of 1,750 shares of common stock.
• The shares were sold at a price of $19.79 per share.
• The transaction date was October 31, 2025.
• Following this transaction, John Turman Fleming directly beneficially owns 4,565 shares of USANA common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.

Sentiment

Score: 4

Explanation: The sale of shares by a director, even if pre-planned under a 10b5-1 plan, can be interpreted with slight caution by the market, as it reduces insider ownership. However, the pre-planned nature mitigates immediate negative sentiment.

Negatives

• A director selling shares, even under a pre-arranged plan, can sometimes be perceived negatively by investors as it reduces insider ownership and might suggest a desire to diversify.

Corporate Governance

Stakeholder Impact

• Shareholders: May view the director's sale as a signal, potentially influencing their perception of the stock's value or future prospects.

Key Dates

Keywords

USANA, USNA, John Turman Fleming, Director, Insider Sale, Form 4, Stock Transaction, 10b5-1 Plan